ClinicalTrials.govpublic full text
A Phase I, Randomized, Open-label, Cross-over, Pharmacokinetic Study of Genasense With and Without Dacarbazine
advanced melanoma, bcl-2, cfr, dtic, ecog, emea, meddra, nci ctc, sae, interventional, phase1
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 882959
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.